Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2 (6), 98-104

Managing Diabetic Macular Edema: The Leading Cause of Diabetes Blindness

Affiliations

Managing Diabetic Macular Edema: The Leading Cause of Diabetes Blindness

Pedro Romero-Aroca. World J Diabetes.

Abstract

Diabetic macular edema (DME) is the leading cause of blindness in young adults in developed countries, affecting 12% of type 1 and 28% of type 2 diabetic patients. The gold standard DME treatment should be based on a good control of glycemia along with control of lipids and renal function. However, despite the systemic metabolic control values being essential for patients with diabetic retinopathy (DR), it has proven to be insufficient for DME if it appears. With these patients, additional measures are needed in order to avoid the subsequent loss of vision. While laser treatment of DME has been the only valid treatment so far, it has been inadequate in chronic cases. The introduction of new treatments, such as intravitreal corticosteroids or anti-VEGF drugs, have recently shown their safety and efficacy and together with laser photocoagulation are becoming the treatments of choice in the management of DME.

Keywords: Diabetic macular edema; Diabetic retinopathy treatment.

Similar articles

See all similar articles

Cited by 27 PubMed Central articles

See all "Cited by" articles
Feedback